{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:17:28Z","timestamp":1793369848607,"version":"4.5.0"},"reference-count":69,"publisher":"Bentham Science Publishers Ltd.","issue":"13","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MRMC"],"published-print":{"date-parts":[[2020,8,20]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>This review explains the effects of naproxen and the naproxen moiety in important biological\nactivities. Naproxen, 2-(6-methoxynaphthalen-2-yl)propionic acid, is one of the most utilized propionic\nacid derivatives to the cure of many injuries or pains. Naproxen is a non-steroidal antiinflammatory\ndrug (NSAID), which is generally used among the NSAIDs. Even though it has gastrointestinal\nside effects, naproxen has been safely used for many years because of the good cardiovascular\nsight. In the past years, except for anti-inflammatory effects, other pharmacological activities of\nnaproxen, especially anticancer and antimicrobial activities, gain the attention of researchers. Naproxen\nshows its activity by inhibiting the COX-2 enzyme. There is significant interest in the possibility\nthat COX-2 inhibitors might retard or prevent the development of various cancer types, which is often\ncharacterized by COX-2 expression. The activities of both naproxen and new molecules derived from\nnaproxen were frequently investigated.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1389557520666200505124922","type":"journal-article","created":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T09:20:12Z","timestamp":1588670412000},"page":"1300-1310","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Anticancer and Antimicrobial Activities of Naproxen and Naproxen Derivatives"],"prefix":"10.2174","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5610-0869","authenticated-orcid":true,"given":"M. \u0130hsan","family":"Han","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Erciyes University, Talas, 38030, Kayseri, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9405-8905","authenticated-orcid":true,"given":"\u015e. G\u00fcniz","family":"K\u00fc\u00e7\u00fckg\u00fczel","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Marmara University, Basibuyuk, 34854, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/ard.33.1.12","volume":"33","author":"Hill, H.F.H.","year":"1974","unstructured":"Hill, H.F.H.; Hill, A.G.S. Naproxen. A new non-hormonal antiin-flammatory agent. Ann. Rheum. Dis. 1974,33,12-19. http:\/\/dx.doi.org\/10.1136\/ard.33.1.12 PMID: 4595271","journal-title":"Anew non-hormonal antiin-flammatory agent.Ann.Rheum.Dis"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s40256-016-0200-5","volume":"17(2)","author":"Angiolillo, D.J.","year":"2017","unstructured":"Angiolillo, D.J.; Weisman, S.M. Clinical Pharmacology and Car-diovascular Safety of Naproxen. Am, J. Cardiovasc. Drugs. 2017,17(2),97-107. http:\/\/dx.doi.org\/10.1007\/s40256-016-0200-5 PMID: 27826802","journal-title":"Am, J.Cardiovasc.Drugs"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0952-3278(96) 90064-2","volume":"54(2)","author":"Lupulescu,A","year":"1996","unstructured":"Lupulescu.; A. Prostaglandins, their inhibitors and cancer. Prosta-glandins Leukot. Essent. Fatty Acids. 1996,54(2),83-94. http:\/\/dx.doi.org\/10.1016\/S0952-3278(96) 90064-2 PMID: 8848435","journal-title":"Prosta-glandins Leukot.Essent.Fatty Acids"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0140-6736(98) 12154-2","volume":"353(9149)","author":"Hawkey,C.J","year":"1999","unstructured":"Hawkey.; C.J. COX-2 inhibitors. Lancet. 1999,353(9149),307-314. http:\/\/dx.doi.org\/10.1016\/S0140-6736(98) 12154-2 PMID: 9929039","journal-title":"Lancet"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3109\/03009749609097226","volume":"102","author":"Vane, J.R.","year":"1996","unstructured":"Vane, J.R.; Botting, R.M. Mechanism of action of anti-inflammatory drugs. Scand, J. Rheumatol. Suppl. 1996,102,9-21. http:\/\/dx.doi.org\/10.3109\/03009749609097226 PMID: 8628981","journal-title":"Scand, J.Rheumatol.Suppl"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1039\/c2tx20018j","volume":"1","author":"Hughes,A.","year":"2012","unstructured":"Hughes,A.; Saunders, F.R.; Wallace, H.M. Naproxen causes cyto-toxicity and induces changes in polyamine metabolism independent of cyclo-oxygenase expression. Toxicol. Res. 2012,1,108-115. http:\/\/dx.doi.org\/10.1039\/c2tx20018j","journal-title":"Toxicol.Res"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1080\/00397911.2017.1328066","volume":"47(15)","author":"Ammar, Y.A.","year":"2017","unstructured":"Ammar, Y.A.; Salem, M.A.; Fayed, E.A.; Helal, M.H.; El-Gaby, M.S.A.; Thabet, H.K. Naproxen derivatives: Synthesis, reactions, and biological applications. Synth. Commun. 2017,47(15),1341-1367. http:\/\/dx.doi.org\/10.1080\/00397911.2017.1328066","journal-title":"Synth.Commun"},{"key":"ref=8","author":"Steele, V.E.","unstructured":"Steele, V.E.; Rao, C.V.; Zhang,Y.; Patlolla,J.; Boring,D.; Kope-lovich,L.; Juliana, M.M.; Grubbs, C.J.; Lubet, R.A. Chemopreven-tive efficacy of naproxen and nitric oxide-naproxen in rodent mo-dels of colon, urinary bladder, and mammary cancers. Cancer Prev. Res. (Phila.),2009,2(11),951-956. http:\/\/dx.doi.org\/10.1158\/1940-6207.CAPR-09-0080 PMID: 19892664","journal-title":"Cancer Prev.Res.(Phila.)"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.juro.2009.12.001","volume":"183(4)","author":"Lubet, R.A.","year":"2010","unstructured":"Lubet, R.A.; Steele, V.E.; Juliana, M.M.; Grubbs, C.J. Screening agents for preventive efficacy in a bladder cancer model: Study de-sign, end points, and gefitinib and naproxen efficacy, J. Urol. 2010,183(4),1598-1603. http:\/\/dx.doi.org\/10.1016\/j.juro.2009.12.001 PMID: 20172542","journal-title":"Urol"},{"key":"ref=10","author":"Kim, M.S.","unstructured":"Kim, M.S.; Kim, J.E.; Lim, D.Y.; Huang,Z.; Chen,H.; Langfald,A.; Lubet, R.A.; Grubbs, C.J.; Dong,Z.; Bode, A.M. Naproxen in-duces cell-cycle arrest and apoptosis in human urinary bladder can-cer cell lines and chemically induced cancers by targeting PI3K. Cancer Prev. Res. (Phila.),2014,7(2),236-245. http:\/\/dx.doi.org\/10.1158\/1940-6207.CAPR-13-0288 PMID: 24327721","journal-title":"Cancer Prev.Res.(Phila.)"},{"key":"ref=11","author":"Nicastro, H.L.","unstructured":"Nicastro, H.L.; Grubbs, C.J.; Margaret Juliana,M.; Bode, A.M.; Kim, M.S.; Lu,Y.; You,M.; Milne, G.L.; Boring,D.; Steele, V.E.; Lubet, R.A. Preventive effects of NSAIDs, NO-NSAIDs, and NSAIDs plus difluoromethylornithine in a chemically induced uri-nary bladder cancer model. Cancer Prev. Res. (Phila.),2014,7(2),246-254. http:\/\/dx.doi.org\/10.1158\/1940-6207.CAPR-13-0164 PMID: 24346344","journal-title":"Cancer Prev.Res.(Phila"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1007\/s11095-008-9596-1","volume":"25(9)","author":"Zrieki,A.","year":"2008","unstructured":"Zrieki,A.; Farinotti,R.; Buyse, M. Cyclooxygenase inhibitors down regulate P-glycoprotein in human colorectal Caco-2 cell line. Pharm. Res. 2008,25(9),1991-2001. http:\/\/dx.doi.org\/10.1007\/s11095-008-9596-1 PMID: 18581209","journal-title":"Pharm.Res"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"6848","DOI":"10.1039\/c3dt53175a","volume":"43(18)","author":"Banti, C.N.","year":"2014","unstructured":"Banti, C.N.; Giannoulis, A.D.; Kourkoumelis,N.; Owczarzak, A.M.; Kubicki,M.; Hadjikakou, S.K. Novel metallo-therapeutics of the NSAID naproxen. Interaction with intracellular components that leads the cells to apoptosis. Dalton Trans. 2014,43(18),6848-6863. http:\/\/dx.doi.org\/10.1039\/c3dt53175a PMID: 24658365","journal-title":"Interaction with intracellular components that leads the cells to apoptosis.Dalton Trans"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1186\/1471-2407-14-567","volume":"14","author":"Deb,J.","year":"2014","unstructured":"Deb,J.; Majumder,J.; Bhattacharyya,S.; Jana, S.S. A novel napro-xen derivative capable of displaying anti-cancer and anti-migratory properties against human breast cancer cells. BMC Cancer. 2014,14,567-574. http:\/\/dx.doi.org\/10.1186\/1471-2407-14-567 PMID: 25098498","journal-title":"BMC Cancer"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"5736","DOI":"10.1002\/chem.201605674","volume":"23(24)","author":"Paul,M.","year":"2017","unstructured":"Paul,M.; Sarkar,K.; Deb,J.; Dastidar, P. Hand-Ground Nanoscale ZnII-Based Coordination Polymers Derived from NSAIDs: Cell migration inhibition of human breast cancer cells. Chemistry. 2017,23(24),5736-5747. http:\/\/dx.doi.org\/10.1002\/chem.201605674 PMID: 28236430","journal-title":"Chemistry"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11010-017-3181-z","volume":"441(1-2)","author":"Wilder, P.T.","year":"2018","unstructured":"Wilder, P.T.; Weber, D.J.; Winstead,A.; Parnell,S.; Hinton, T.V.; Stevenson,M.; Giri,D.; Azemati,S.; Olczak,P.; Powell, B.V.; Odebode,T.; Tadesse,S.; Zhang,Y.; Pramanik, S.K.; Wachira, J.M.; Ghimire,S.; McCarthy,P.; Barfield,A.; Banerjee, H.N.; Chen,C.; Golen, J.A.; Rheingold, A.L.; Krause, J.A.; Ho, D.M.; Zavalij, P.Y.; Shaw,R.; Mandal, S.K. Unprecedented anticancer activities of organorhenium sulfonato and carboxylato complexes against hormone-dependent MCF-7 and hormone-independent tri-ple-negative MDA-MB-231 breast cancer cells. Mol. Cell. Bio-chem. 2018,441(1-2),151-163. http:\/\/dx.doi.org\/10.1007\/s11010-017-3181-z PMID: 28913709","journal-title":"Mol.Cell.Bio-chem"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/aoc.4763","volume":"33(4763)","author":"Tolan, D.A.","year":"2019","unstructured":"Tolan, D.A.; Abdel-Monem, Y.K.; El-Nagar, M.A. Anti-tumor platinum (IV)  complexes bearing the anti-inflammatory drug na-proxen in the axial position. Appl. Organomet. Chem. 2019,33(4763),1-12. http:\/\/dx.doi.org\/10.1002\/aoc.4763","journal-title":"Appl.Organomet.Chem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1021\/acs.chemrestox.9b00087","volume":"32(8)","author":"Bharathi,S.","year":"2019","unstructured":"Bharathi,S.; Mahendiran,D.; Kumar, R.S.; Kim, Y.G.; Gajendiran,M.; Kim,K.; Rahiman, A.K. Biocompatibility, in vitro antiprolife-rative, and in silico EGFR\/VEGFR2 studies of heteroleptic me-tal(II)  complexes of thiosemicarbazones and naproxen. Chem. Res. Toxicol. 2019,32(8),1554-1571. http:\/\/dx.doi.org\/10.1021\/acs.chemrestox.9b00087 PMID: 31241919","journal-title":"Chem.Res.Toxicol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"17126","DOI":"10.1021\/am5047872","volume":"6(19)","author":"Deshpande,S.","year":"2014","unstructured":"Deshpande,S.; Venugopal,E.; Ramagiri,S.; Bellare, J.R.; Kuma-raswamy,G.; Singh, N. Enhancing cubosome functionality by coa-ting with a single layer of poly-e-lysine. ACS Appl. Mater. Interfa-ces. 2014,6(19),17126-17133. http:\/\/dx.doi.org\/10.1021\/am5047872 PMID: 25184793","journal-title":"ACS Appl.Mater.Interfa-ces"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/1471-2407-8-237","volume":"8(237)","author":"Harris, R.E.","year":"2008","unstructured":"Harris, R.E.; Beebe-Donk,J.; Alshafie, G.A. Similar reductions in the risk of human colon cancer by selective and nonselective cy-clooxygenase-2 (COX-2)  inhibitors. BMC Cancer. 2008,8(237),237. http:\/\/dx.doi.org\/10.1186\/1471-2407-8-237 PMID: 18702823","journal-title":"BMC Cancer"},{"key":"ref=21","author":"Suh,N.","unstructured":"Suh,N.; Reddy, B.S.; DeCastro,A.; Paul,S.; Lee, H.J.; Smolarek, A.K.; So, J.Y.; Simi,B.; Wang, C.X.; Janakiram, N.B.; Steele,V.; Rao, C.V. Combination of atorvastatin with sulindac or naproxen profoundly inhibits colonic adenocarcinomas by suppressing the p65\/\u00df-catenin\/cyclin D1 signaling pathway in rats. Cancer Prev. Res. (Phila.),2011,4(11),1895-1902. http:\/\/dx.doi.org\/10.1158\/1940-6207.CAPR-11-0222 PMID: 21764859","journal-title":"Cancer Prev.Res.(Phila.)"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1007\/s00044-014-0979-z","volume":"23(9)","author":"Aboul-Fadl,T.","year":"2014","unstructured":"Aboul-Fadl,T.; Al-Hamad, S.S.; Lee,K.; Li,N.; Gary, B.D.; Kee-ton, A.B.; Piazza, G.A.; Abdel-Hamid, M.K. Novel non-cyclooxygenase inhibitory derivatives of naproxen for colorectal cancer chemoprevention. Med. Chem. Res. 2014,23(9),4177-4188. http:\/\/dx.doi.org\/10.1007\/s00044-014-0979-z PMID: 27559271","journal-title":"Med.Chem.Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1042\/bj20030280","volume":"374(Pt 2)","author":"Hughes,A.","year":"2003","unstructured":"Hughes,A.; Smith, N.I.; Wallace, H.M. Polyamines reverse non-steroidal anti-inflammatory drug-induced toxicity in human colo-rectal cancer cells. Biochem, J. 2003,374(Pt 2),481-488. http:\/\/dx.doi.org\/10.1042\/bj20030280 PMID: 12793857","journal-title":"Biochem, J"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.bioorg.2017.12.006","volume":"76","author":"Aboul-Fadl,T.","year":"2018","unstructured":"Aboul-Fadl,T.; Al-Hamad, S.S.; Fouad, E.A. Pharmacokinetic studies of naproxen amides of some amino acid esters with promi-sing colorectal cancer chemopreventive activity. Bioorg. Chem. 2018,76,370-379. http:\/\/dx.doi.org\/10.1016\/j.bioorg.2017.12.006 PMID: 29241109","journal-title":"Bioorg.Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.poly.2007.12.011","volume":"27","author":"Ribeiro,G.","year":"2008","unstructured":"Ribeiro,G.; Benadiba,M.; Colquhoun,A.; Silva, B.O. Diruthe-nium(II, III)  complexes of ibuprofen, aspirin, Naproxen and indo-methacin non-steroidal anti-inflammatory drugs: Synthesis, charac-terization and their effects on tumor-cell proliferation. Polyhedron. 2008,27,1131-1137. http:\/\/dx.doi.org\/10.1016\/j.poly.2007.12.011","journal-title":"Polyhedron"},{"key":"ref=26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinorgbio.2019.110984","author":"Alves, S.R.","unstructured":"Alves, S.R.; Colquhoun,A.; Wu, X.Y.; de Oliveira Silva, D. Synt-hesis of terpolymer-lipid encapsulated diruthenium(II, III)-anti-inflammatory metallodrug nanoparticles to enhance activity against glioblastoma cancer cells, J. Inorg. Biochem. 2020,205110984 http:\/\/dx.doi.org\/10.1016\/j.jinorgbio.2019.110984 PMID: 31927403","journal-title":"Inorg.Biochem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"e00224","DOI":"10.1002\/prp2.224","volume":"4(2)","author":"Chattopadhyay,M.","year":"2016","unstructured":"Chattopadhyay,M.; Kodela,R.; Duvalsaint, P.L.; Kashfi, K. Gas-trointestinal safety, chemotherapeutic potential, and classic phar-macological profile of NOSH-naproxen (AVT-219)  a dual NO-and H2S-releasing hybrid. Pharmacol. Res. Perspect. 2016,4(2),e00224. http:\/\/dx.doi.org\/10.1002\/prp2.224 PMID: 27069635","journal-title":"Pharmacol.Res.Perspect"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ejmech.2017.12.025","volume":"144","author":"Srivastava,P.","year":"2018","unstructured":"Srivastava,P.; Singh,K.; Verma,M.; Sivakumar,S.; Patra, A.K. Photoactive platinum(II)  complexes of nonsteroidal anti-inflammatory drug naproxen: Interaction with biological targets, antioxidant activity and cytotoxicity. Eur, J. Med. Chem. 2018,144,243-254. http:\/\/dx.doi.org\/10.1016\/j.ejmech.2017.12.025 PMID: 29274491","journal-title":"Eur, J.Med.Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.msec.2016.08.024","volume":"69","author":"Kumar,R.","year":"2016","unstructured":"Kumar,R.; Siril, P.F.; Javid, F. Unusual anti-leukemia activity of nanoformulated naproxen and other non-steroidal anti-inflammatory drugs. Mater. Sci. Eng. C. 2016,69,1335-1344. http:\/\/dx.doi.org\/10.1016\/j.msec.2016.08.024 PMID: 27612834","journal-title":"Mater.Sci.Eng.C"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ica.2019.01.030","volume":"489","author":"Tabares, J.P.G.","year":"2019","unstructured":"Tabares, J.P.G.; Santos, R.L.S.R.; Cassiano, J.L.; Zaim, M.H.; Honorato,J.; Batista, A.A.; Teixeira, S.F.; Ferreira, A.K.; Viana, R.B.; Mart\u00ednez, S.Q.; St\u00e1bile, A.C.; Silva, D.O.A. Ru(II)-p-cymene compound bearing naproxen-pyridineamide. Synthesis, spectrosco-pic studies, computational analysis and in vitro anticancer activity against lung cells compared to Ru(II)-p-cymene-naproxen and the corresponding drug ligands. Inorg. Chim. Acta. 2019,489,27-38. http:\/\/dx.doi.org\/10.1016\/j.ica.2019.01.030","journal-title":"Synthesis, spectrosco-pic studies, computational analysis and in vitro anticancer activity against lung cells compared to Ru(II)-p-cymene-naproxen and the corresponding drug ligands.Inorg.Chim.Acta"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF02685897","volume":"24(1)","author":"Kast,R.E","year":"2007","unstructured":"Kast.; R.E. Melanoma inhibition by cyclooxygenase inhibitors: Role of interleukin-6 suppression, a putative mechanism of action, and clinical implications. Med. Oncol. 2007,24(1),1-6. http:\/\/dx.doi.org\/10.1007\/BF02685897 PMID: 17673806","journal-title":"Med.Oncol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.taap.2012.07.029","volume":"264(2)","author":"Cheng,H.","year":"2012","unstructured":"Cheng,H.; Mollica, M.Y.; Lee, S.H.; Wang,L.; Vel\u00e1zquez-Mart\u00ednez, C.A.; Wu, S. Effects of nitric oxide-releasing nonsteroi-dal anti-inflammatory drugs (NONO-NSAIDs)  on melanoma cell adhesion. Toxicol. Appl. Pharmacol. 2012,264(2),161-166. http:\/\/dx.doi.org\/10.1016\/j.taap.2012.07.029 PMID: 22889880","journal-title":"Toxicol.Appl.Pharmacol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3389\/fphar.2019.00066","volume":"10(66)","author":"Ercolano,G.","year":"2019","unstructured":"Ercolano,G.; De Cicco,P.; Frecentese,F.; Saccone,I.; Corvino,A.; Giordano,F.; Magli,E.; Fiorino,F.; Severino,B.; Calderone,V.; Citi,V.; Cirino,G.; Ianaro, A. Anti-metastatic properties of na-proxen-HBTA in a murine model of cutaneous melanoma. Front. Pharmacol. 2019,10(66),66. http:\/\/dx.doi.org\/10.3389\/fphar.2019.00066 PMID: 30800067","journal-title":"Front.Pharmacol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1248\/cpb.53.1062","volume":"53(8)","author":"Takeuchi,Y.","year":"2005","unstructured":"Takeuchi,Y.; Fujisawa,H.; Fujiwara,T.; Matsuura,M.; Komatsu,H.; Ueno,S.; Matsuzaki, T. Biological evaluation of 2-aryl-2-fluoropropionic acids as possible platforms for new medicinal agents. Chem. Pharm. Bull. (Tokyo). 2005,53(8),1062-1064. http:\/\/dx.doi.org\/10.1248\/cpb.53.1062 PMID: 16079551","journal-title":"Chem.Pharm.Bull.(Tokyo)"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s11010-006-2568-z","volume":"283(1-2)","author":"Morr\u00e9, D.J.","year":"2006","unstructured":"Morr\u00e9, D.J.; Morre, D.M. tNOX, an alternative target to COX-2 to explain the anticancer activities of non-steroidal anti-inflammatory drugs (NSAIDS) . Mol. Cell. Biochem. 2006,283(1-2),159-167. http:\/\/dx.doi.org\/10.1007\/s11010-006-2568-z PMID: 16444599","journal-title":"Mol.Cell.Biochem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1039\/c3md00185g","volume":"4(11)","author":"Kodela,R.","year":"2013","unstructured":"Kodela,R.; Chattopadhyay,M.; Kashfi, K. Synthesis and biologi-cal activity of NOSH-naproxen (AVT-219)  and NOSH-sulindac (AVT-18A)  as potent anti-inflammatory agents with chemothera-peutic potential. Med. Chem. Comm. 2013,4(11),1-20. http:\/\/dx.doi.org\/10.1039\/c3md00185g PMID: 24273639","journal-title":"Med.Chem.Comm"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1002\/adhm.201300638","volume":"3(9)","author":"Chen,L.","year":"2014","unstructured":"Chen,L.; Jiang,T.; Cai,C.; Wang,L.; Lin,J.; Cao, X. Polypeptide-based \u201csmart\u201d micelles for dual-drug delivery: A combination study of experiments and simulations. Adv. Healthc. Mater. 2014,3(9),1508-1517. http:\/\/dx.doi.org\/10.1002\/adhm.201300638 PMID: 24652770","journal-title":"Adv.Healthc.Mater"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3109\/14756366.2012.762645","volume":"29(2)","author":"Motawi, T.M.K.","year":"2014","unstructured":"Motawi, T.M.K.; Bustanji,Y.; El-Maraghy,S.; Taha, M.O.; Al-Ghussein, M.A. Evaluation of naproxen and cromolyn activities against cancer cells viability, proliferation, apoptosis, p53 and gene expression of survivin and caspase-3. J. Enzyme Inhib. Med. Chem. 2014,29(2),153-161. http:\/\/dx.doi.org\/10.3109\/14756366.2012.762645 PMID: 23368763","journal-title":"J.Enzyme Inhib.Med.Chem"},{"key":"ref=39","author":"Lubet, R.A.","unstructured":"Lubet, R.A.; Scheiman, J.M.; Bode,A.; White,J.; Minasian,L.; Juliana, M.M.; Boring, D.L.; Steele, V.E.; Grubbs, C.J. Prevention of chemically induced urinary bladder cancers by naproxen: proto-cols to reduce gastric toxicity in humans do not alter preventive ef-ficacy. Cancer Prev. Res. (Phila.),2015,8(4),296-302. http:\/\/dx.doi.org\/10.1158\/1940-6207.CAPR-14-0347 PMID: 25762530","journal-title":"Cancer Prev.Res.(Phila.)"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"7895","DOI":"10.1039\/C5NJ01059D","volume":"39","author":"Mahendiran,D.","year":"2015","unstructured":"Mahendiran,D.; Gurumoorthy,P.; Gunasekaran,K.; Kumar, R.S.; Rahiman, A.K. Structural modeling, in vitro antiproliferative acti-vity, and the effect of substituents on the DNA fastening and scis-sion actions of heteroleptic copper (II)  complexes with terpyridines and Naproxen. New J. Chem. 2015,39,7895-7911. http:\/\/dx.doi.org\/10.1039\/C5NJ01059D","journal-title":"New J.Chem"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"11366","DOI":"10.1002\/chem.201701939","volume":"23(47)","author":"Lu,C.","year":"2017","unstructured":"Lu,C.; Eskandari,A.; Cressey, P.B.; Suntharalingam, K. Cancer stem cell and bulk cancer cell active copper(ii)  complexes with va-nillin schiff base derivatives and naproxen. Chemistry. 2017,23(47),11366-11374. http:\/\/dx.doi.org\/10.1002\/chem.201701939 PMID: 28658520","journal-title":"Chemistry"},{"key":"ref=42","first-page":"1","volume":"00","author":"Rico, S.R.A.","year":"2016","unstructured":"Rico, S.R.A.; Abbasi, A.Z.; Ribeiro,G.; Ahmed,T.; Wu, Z.Y.; Silva, D.O. Diruthenium(II, III)  metallodrugs of ibuprofen and Na-proxen encapsulated in intravenously injectable polymer-lipid na-noparticles exhibit enhanced activity against breast and prostate cancer cells. Nanoscale. 2016,00,1-11","journal-title":"Nanoscale"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ejmech.2018.09.007","volume":"158","author":"El-Husseiny, W.M.","year":"2018","unstructured":"El-Husseiny, W.M.; El-Sayed, M.A.A.; Abdel-Aziz, N.I.; El-Azab, A.S.; Asiri, Y.A.; Abdel-Aziz, A.A.M. Structural alterations based on naproxen scaffold: Synthesis, evaluation of antitumor activity and COX-2 inhibition, and molecular docking. Eur, J. Med. Chem. 2018,158,134-143. http:\/\/dx.doi.org\/10.1016\/j.ejmech.2018.09.007 PMID: 30216848","journal-title":"Eur, J.Med.Chem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.poly.2019.04.009","volume":"172","author":"Srivastava,P.","year":"2019","unstructured":"Srivastava,P.; Mishra,R.; Verma,M.; Sivakumar,S.; Patra, A.K. Cytotoxic ruthenium(II)  polypyridyl complexes with naproxen as NSAID: Synthesis, biological interactions and antioxidant activity. Polyhedron. 2019,172,132-140. http:\/\/dx.doi.org\/10.1016\/j.poly.2019.04.009","journal-title":"Polyhedron"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00280-003-0708-7","volume":"53(2)","author":"Molinuevo, M.S.","year":"2004","unstructured":"Molinuevo, M.S.; Barrio, D.A.; Cortizo, A.M.; Etcheverry, S.B. Antitumoral properties of two new vanadyl(IV)  complexes in os-teoblasts in culture: Role of apoptosis and oxidative stress. Cancer Chemother. Pharmacol. 2004,53(2),163-172. http:\/\/dx.doi.org\/10.1007\/s00280-003-0708-7 PMID: 14551736","journal-title":"Cancer Chemother.Pharmacol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1080\/15287394.2014.911131","volume":"77(14-16)","author":"Correia,I.","year":"2014","unstructured":"Correia,I.; Arantes-Rodrigues,R.; Pinto-Leite,R.; Gaiv\u00e3o, I. Ef-fects of naproxen on cell proliferation and genotoxicity in MG-63 osteosarcoma cell line, J. Toxicol. Environ. Health A. 2014,77(14-16),916-923. http:\/\/dx.doi.org\/10.1080\/15287394.2014.911131 PMID: 25072723","journal-title":"Toxicol.Environ.Health A"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"e1800379","DOI":"10.1002\/ardp.201800379","volume":"352(8)","author":"Shokri,B.","year":"2019","unstructured":"Shokri,B.; Zarghi,A.; Shahhoseini,S.; Mohammadi,R.; Kobar-fard, F. Design, synthesis and biological evaluation of peptide-NSAID conjugates for targeted cancer therapy. Arch. Pharm. (Weinheim). 2019,352(8),e1800379. http:\/\/dx.doi.org\/10.1002\/ardp.201800379 PMID: 31318093","journal-title":"Arch.Pharm.(Weinheim)"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3892\/ijmm.13.6.789","volume":"13(6)","author":"Yoshimura,R.","year":"2004","unstructured":"Yoshimura,R.; Matsuyama,M.; Kawahito,Y.; Takemoto,Y.; Tsuchida,K.; Kuratsukuri,K.; Segawa,Y.; Shinnka,T.; Sano,H.; Nakatani, T. The effects of cyclooxygenase-2 inhibitors on urologi-cal cancer cells. Int, J. Mol. Med. 2004,13(6),789-793. http:\/\/dx.doi.org\/10.3892\/ijmm.13.6.789 PMID: 15138613","journal-title":"Int, J.Mol.Med"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"7917","DOI":"10.1158\/0008-5472.CAN-05-1435","volume":"65(17)","author":"Moreno,J.","year":"2005","unstructured":"Moreno,J.; Krishnan, A.V.; Swami,S.; Nonn,L.; Peehl, D.M.; Feldman, D. Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells. Cancer Res. 2005,65(17),7917-7925. http:\/\/dx.doi.org\/10.1158\/0008-5472.CAN-05-1435 PMID: 16140963","journal-title":"Cancer Res"},{"key":"ref=50","first-page":"3605","volume":"29(9)","author":"Srinivas,S.","year":"2009","unstructured":"Srinivas,S.; Feldman, D. A phase II trial of calcitriol and naproxen in recurrent prostate cancer. Anticancer Res. 2009,29(9),3605-3610. PMID: 19667155","journal-title":"Anticancer Res"},{"key":"ref=51","first-page":"393","volume":"2(6)","author":"Nakka,M.","year":"2010","unstructured":"Nakka,M.; Begum, M.S.; Varaprasad, B.F.M.; Reddy, L.V.; Bhat-tacharya,A.; Helliwell,M.; Mukherjee, A.K.; Beevi, S.S.; Manga-moori, L.N.; Mukkanti,M.; Pal, S. Naproxen and ibuprofen based acyl hydrazone derivatives: Synthesis, structure analysis and cyto-toxicity studies, J. Chem. Pharm. Res. 2010,2(6),393-409","journal-title":"Chem.Pharm..Res"},{"key":"ref=52","author":"Adeniji,A.","unstructured":"Adeniji,A.; Uddin, M.J.; Zang,T.; Tamae,D.; Wangtrakuldee,P.; Marnett, L.J.; Penning, T.M. Discovery of (R). 2-(6-methoxynaphthalen-2-yl) butanoic acid as a potent and selective al-do-keto reductase 1C3 inhibitor, J. Med. Chem. 2016,59(16),7431-7444. http:\/\/dx.doi.org\/10.1021\/acs.jmedchem.6b00160 PMID: 27486833"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"e1800365","DOI":"10.1002\/ardp.201800365","volume":"352(6)","author":"Han, M.I.","year":"2019","unstructured":"Han, M.I.; Bek\u00e7i,H.; Uba, A.I.; Yildirim,Y.; Karasulu,E.; Cu-maoglu,A.; Karasulu, H.Y.; Yelek\u00e7i,K.; Yilmaz, \u00d6.; K\u00fc\u00e7\u00fckg\u00fczel, S.G. Synthesis, molecular modeling, in vivo study, and anticancer activity of 1,2,4-triazole containing hydrazide-hydrazones derived from (S)-naproxen. Arch. Pharm. (Weinheim). 2019,352(6),e1800365. http:\/\/dx.doi.org\/10.1002\/ardp.201800365 PMID: 31115928","journal-title":"Arch.Pharm.(Weinheim)"},{"key":"ref=54","first-page":"559","volume":"22(4)","author":"Han, M.I.","year":"2018","unstructured":"Han, M.I.; Bek\u00e7i,H.; Cumaoglu,A.; K\u00fc\u00e7\u00fckg\u00fczel, S.G. Synthesis and characterization of 1,2,4-triazole containing hydrazide-hydrazones derived from (S)-Naproxen as anticancer agents. Mar-mara Pharm, J. 2018,22(4),559-569","journal-title":"Mar-mara Pharm, J"},{"key":"ref=55","first-page":"547","volume":"10(3)","author":"Abdul,Hussein,A.;,Al-Janabi.","year":"2011","unstructured":"Abdul Hussein,A.; Al-Janabi, S. Investigation of anti-dermatophytic effects of non-steroidal anti-inflammatory drugs on trichophyton mentagrophytes and epidermophyton floccosum. Iran, J. Pharm. Res. 2011,10(3),547-552. PMID: 24250387","journal-title":"Iran, J.Pharm..Res"},{"key":"ref=56","first-page":"1","volume":"4","author":"Mamatha,N.","year":"2011","unstructured":"Mamatha,N.; Babu, N.S.; Mukkanti,K.; Pal, S. 2-(6-methoxynaphthalen-2-yl) propionic acid (1,3-dimethyl-butylidene)-hydrazide. Molbank. 2011,4,1-4","journal-title":"Molbank"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1128\/AAC.02335-12","volume":"57(5)","author":"Lejal,N.","year":"2013","unstructured":"Lejal,N.; Tarus,B.; Bouguyon,E.; Chenavas,S.; Bertho,N.; Del-mas,B.; Ruigrok, R.W.H.; Di Primo,C.; Slama-Schwok, A. Struc-ture-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus. Antimicrob. Agents Chemother. 2013,57(5),2231-2242. http:\/\/dx.doi.org\/10.1128\/AAC.02335-12 PMID: 23459490","journal-title":"Antimicrob.Agents Chemother"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.saa.2014.02.135","volume":"128","author":"Chiniforoshan,H.","year":"2014","unstructured":"Chiniforoshan,H.; Tabrizi,L.; Hadizade,M.; Sabzalian, M.R.; Chermahini, A.N.; Rezapour, M. Anti-inflammatory drugs interac-ting with Zn (II)  metal ion based on thiocyanate and azide ligands: synthesis, spectroscopic studies, DFT calculations and antibacterial assays. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2014,128,183-190. http:\/\/dx.doi.org\/10.1016\/j.saa.2014.02.135 PMID: 24667423","journal-title":"Spectrochim.Acta A Mol.Biomol.Spectrosc"},{"key":"ref=59","first-page":"2026","volume":"3(2)","author":"Fernandes,J.","year":"2014","unstructured":"Fernandes,J.; Kumar,A.; Kumar,P.; Singh,S.; Meet,B.; Raju,B.; Mahaveer, J. Synthesis, anti-inflammatory and antimicrobial activi-ty of some novel carboxamide derivatives of Naproxen. World J. Pharm. Pharm. Sci. 2014,3(2),2026-2034","journal-title":"World J.Pharm..Pharm.Sci"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1080\/00958972.2014.891198","volume":"67(4)","author":"Caglar,S.","year":"2014","unstructured":"Caglar,S.; Adiguzel,E.; Sariboga,B.; Temel,E.; Buyukgungor, O. Mono and dinuclear copper(II)  naproxenato complexes containing 3-picoline and 4-picoline: Synthesis, structure, properties, catechol oxidase, and antimicrobial activities, J. Coord. Chem. 2014,67(4),670-683. http:\/\/dx.doi.org\/10.1080\/00958972.2014.891198","journal-title":"Coord.Chem"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1080\/07391102.2014.979230","volume":"33(9)","author":"Tarus,B.","year":"2015","unstructured":"Tarus,B.; Bertrand,H.; Zedda,G.; Di Primo,C.; Quideau,S.; Slama-Schwok, A. Structure-based design of novel naproxen deri-vatives targeting monomeric nucleoprotein of Influenza A virus, J. Biomol. Struct. Dyn. 2015,33(9),1899-1912. http:\/\/dx.doi.org\/10.1080\/07391102.2014.979230 PMID: 25333630","journal-title":"Biomol.Struct.Dyn"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ejmech.2014.10.032","volume":"89","author":"Abu,Ali,H.;","year":"2015","unstructured":"Abu Ali,H.; Fares,H.; Darawsheh,M.; Rappocciolo,E.; Akkawi,M.; Jaber, S. Synthesis, characterization and biological activity of new mixed ligand complexes of Zn(II)  naproxen with nitrogen ba-sed ligands. Eur, J. Med. Chem. 2015,89,67-76. http:\/\/dx.doi.org\/10.1016\/j.ejmech.2014.10.032 PMID: 25462227","journal-title":"Eur, J.Med.Chem"},{"key":"ref=63","first-page":"245","volume":"5(6)","author":"Ammar, Y.A.","year":"2015","unstructured":"Ammar, Y.A.; Fayed, E.A.; Bayoumi, A.H.; Saleh, M.A.; El-Araby, M.E. Design and synthesis of pyridine-amide based com-pounds appended naproxen moiety as anti-microbial and anti-inflammatory agents. Am, J. PharmTech. Res. 2015,5(6),245-273","journal-title":"Am, J.PharmTech..Res"},{"key":"ref=64","first-page":"63","volume":"7(4)","author":"Hasan,S.","year":"2015","unstructured":"Hasan,S.; Begum, F. Transition metal complexation with naproxen and evaluation of their in vitro antimicrobial, cytotoxic and anthel-mintic properties. Int, J. Curr. Pharm. Res. 2015,7(4),63-69","journal-title":"Int, J.Curr..Pharm.Res"},{"key":"ref=65","first-page":"16","volume":"1(4)","author":"Sabah,M.","year":"2015","unstructured":"Sabah,M.; Jabor, M.A. Preparation of nanohybrid compound from the drugs (Naproxen and cephalexin)  with zinc oxide and studying biological activities against Aeromonas bacteria, J. Contemp. Med. Sci. 2015,1(4),16-19","journal-title":"Contemp.Med..Sci"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"5212","DOI":"10.1016\/j.bmcl.2016.09.059","volume":"26(21)","author":"Neeraja,P.","year":"2016","unstructured":"Neeraja,P.; Srinivas,S.; Mukkanti,K.; Dubey, P.K.; Pal, S. 1H-1,2,3-Triazolyl-substituted 1,3,4-oxadiazole derivatives containing structural features of ibuprofen\/naproxen: Their synthesis and anti-bacterial evaluation. Bioorg. Med. Chem. Lett. 2016,26(21),5212-5217. http:\/\/dx.doi.org\/10.1016\/j.bmcl.2016.09.059 PMID: 27727124","journal-title":"Bioorg.Med.Chem.Lett"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"e0147131","DOI":"10.1371\/journal.pone.0147131","volume":"11(1)","author":"Laudy, A.E.","year":"2016","unstructured":"Laudy, A.E.; Mrowka,A.; Krajewska,J.; Tyski, S. The influence of efflux pump inhibitors on the activity of non-antibiotic nsaids against gram-negative rods. PLoS One. 2016,11(1),e0147131. http:\/\/dx.doi.org\/10.1371\/journal.pone.0147131 PMID: 26771525","journal-title":"PLoS One"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1007\/s00044-017-1939-1","volume":"26","author":"Eissa, S.I.","year":"2017","unstructured":"Eissa, S.I.; Farrag, A.M.; Shawer, T.Z.; Ammar, Y.A. Design, synthesis, 3D pharmacophore, QSAR, and docking studies of some new (6-methoxy-2-naphthyl)  propanamide derivatives with expec-ted anti-bacterial activity as FABI inhibit\u00f6r. Med. Chem. Res. 2017,26,2375-2398. http:\/\/dx.doi.org\/10.1007\/s00044-017-1939-1","journal-title":"Med.Chem.Res"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.3390\/molecules24071237","volume":"24(7)","author":"Shaheen, M.A.","year":"2019","unstructured":"Shaheen, M.A.; Feng,S.; Anthony,M.; Tahir, M.N.; Hassan,M.; Seo, S.Y.; Ahmad,S.; Iqbal,M.; Saleem,M.; Lu, C. Metal-Based scaffolds of schiff bases derived from naproxen: Synthesis, antibac-terial activities, and molecular docking studies. Molecules. 2019,24(7),1237-1239. http:\/\/dx.doi.org\/10.3390\/molecules24071237 PMID: 30934936","journal-title":"Molecules"}],"container-title":["Mini-Reviews in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/181678","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T11:30:18Z","timestamp":1605180618000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/181678\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,20]]},"references-count":69,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2020,8,20]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389557520666200505124922","relation":{},"ISSN":["1389-5575"],"issn-type":[{"value":"1389-5575","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,20]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-12-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}